Friday, 24 January 2020

Robotic Process Automation Market Reveals Growth Potential, Market Expected To Growth At A CAGR Of 29.5%

New York, NY 24 Jan 2020: The robotic process automation (RPA) market size is anticipated to reach USD 8,781.2 million by 2026 growing at a CAGR of 29.5%. Requirement of businesses to eliminate human errors due to manual interference in processes along with reduction in time consumption are factors responsible for positively influencing the adoption rate of RPA technology.


Previously artificial intelligence and robotic process automation were largely considered to be different technologies. But, with advancements in the offerings it is observed these technologies are complimenting each other in terms of handling processes. It enables organizations in processing huge volumes of data and in providing support for better decision making. Cognitive computing which covers wide array of areas including adaptive learning, speech recognition, and pattern identification is integrated in robotic process automation (RPA) solutions to transform and automate crucial business processes of organizations across multiple industry verticals.


The potential of achieving robust ROI from deployment of RPA completely dependent on the organizational requirements and business processes which are to be automated. In the near future, the market is expected to witness growing base of RPA vendors as they target to gain revenue share from this expanding market. This is expected through introduction of solutions which will cater to the rising need to automate business process management processes. Furthermore, the adoption is expected to intensify as the prices of RPA deployment are continually witnessing a declining trend. Moreover, this technology adoption provides organizations the capability to accomplish better outcomes from their process with benefits including reduction in costs, improved accuracy, and better compliance.

However, factors like reluctance in the transition phase from conventional business process to automation along with shortage in technical expertise required during deployment and integration of RPA solution are challenges which might affect the growth in this market. roThis market report includes insights with market size and forecast by process, by operation, by type, by industry, and by organization size. Analysis for each region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) is provided for all segmentation of the robotic process automation market research report.


North America is expected to be largest regional market while Asia Pacific regional market is expected to witness significant growth during the forecast period of 2018 to 2026. The region’s leading position is attributed to significant demand and preference of the BFSI industry vertical towards automation of business processes. Furthermore, presence of established and major players in North America region and availability of infrastructure for effective adoption of RPA is another factor responsible for the boost in adoption of robotic process automation solutions.

European region is expected to witness growth in this market as the region has a presence of significant amount of companies in the manufacturing and logistics sector. Adoption of RPA technology provides the capability to streamline pickup and drop operations. This eventually leads to reduction in cycle time ultimately resulting in enhanced customer experience.

The major key players operating in the robotic process automation (RPA) market include Blue Prism Group Plc (UK), Celaton Ltd. (UK), Softomotive (UK), Kofax Ltd. (U.S.), Xerox Corporation (U.S.), Automation Anywhere Inc. (U.S.), Ipsoft, Inc. (U.S.), UiPath (U.S.), Verint Systems Inc. (U.S.), Pegasystems Inc. (U.S.), Redwood Software (Netherlands), Daythree Business Services sdn bhd (Malaysia), and Kryon Systems (Israel)..

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

ContactUs:
Polaris Market Research
Phone: 1–646–568–9980
Email: sales@polarismarketresearch.com
Web:www.polarismarketresearch.com




Thursday, 16 January 2020

Field Device Management (FDM) Market Strategies and Insight Driven Transformation 2019-2026


New York, NY 16 Jan 2020 : The global field device management (FDM) market size is expected to reach USD 1,700.1 Million by 2026 according to a new study by Polaris Market Research. The report “Field Device Management (FDM) Market Share, Size, Trends, Industry Analysis Report By Component (Hardware, Software); By Deployment (Cloud, On-premises); By Communication Protocol; By Application (Oil & Gas, Energy & Power, Chemicals, Pharmaceuticals, Metals & Mining, Water & Wastewater, Automotive, Manufacturing); By Regions, Segment Forecast, 2019 – 2026” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Due to developments in hardware technologies, demand is increasing in the global device management market. In terms of market growth, the need to manage all peripheral devices within a company has played a vital role. Timely improvements in device configuration are a major requirement in all major industries. In addition, industrial units and plants require a high degree of flexibility and adaptation within their devices. Therefore, the global industry for FDM in the following years is projected to generate huge revenues.


In 2018, the global market was dominated by FDM software, which has the highest share and will be expected to increase at a significant growth rate during the forecast period. The growth of the segment depends primarily on the increasing use in different industries of automation technology, Industry 4.0, and the IoT. Software for field device management can be used to carry out preventive maintenance and management tasks. The tools help the classification and management of collected information such as inspection notes, inspection timetables and system configuration information.

In addition, software solutions for field device management provide remote access to smart devices and machine data that can be used to prevent predictive maintenance. These benefits help to make high use of the software for managing filed devices and thus promote market growth.

North America has the largest market share of nearly 35 per cent of the overall worldwide revenue in the field of device management. In the high-market size of field device management systems in this area, North America, in particular, plays a key role. With a technological boom in the industrial environment, the adoption of field device management systems is growing fast in the United States. In addition, the majority of companies in this market operate in the United States and have a large client base in local and international markets, which contributes in large part to the existing volume of the market in this regional segment.


The demand for FDM solutions for the nonstop monitoring of processes and machinery of these industries is driven by development in industries such as power, electricity, oil & gas and chemical products in the Asia-pacific region. Furthermore, the growth rates in this region of field device management systems also increase the expansion of international players.

Some of the key players in the market are Schneider Electric SE, Honeywell International Inc., Siemens AG, ABB Group, Emerson, Rockwell Automation, Mitsubishi Electric, Hach, Omron Corporation, Metso Oyj, FANUC Corporation, Yokogawa, Hamilton Company, Valmet Oyj, Phoenix Contact,  Endress+Hauser, Festo, Azbil Corporation, Weidmüller and Omega Engineering among others.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




Fuel Cell Market Analysis examined in new market research report


New York, NY 16 Jan 2020 :The global fuel cell market is estimated to reach USD 13.71 billion by 2026 growing at a CAGR of 17.5% during the forecast period, according to a new study published by Polaris Market Research. The report ‘Fuel Cell Market Share, Size, Trends, & Industry Analysis Report, By Type (Solid Oxide Fuel Cells, Phosphoric Acid Fuel Cells, Proton Exchange Membrane Fuel Cells, Molten Carbonate Fuel Cells); By Application; By Region: Segment Forecast, 2019 – 2026’ provides an extensive analysis of present market dynamics and predicted future trends. In 2018, the stationary application segment dominated the global market in terms of revenue. Asia-Pacific is expected to be the leading contributor to the global market revenue during the forecast period.

Government regulations and favorable public initiatives regarding energy consumption have boosted the adoption of fuel cell. Growing concerns regarding environment, increasing demand for unconventional energy sources, and increasing adoption of power efficient energy systems further support the market growth. Additionally, higher efficiency offered by fuel cells as compared to other power generating systems, and growth in adoption of distributed power system would boost the market growth during the forecast period.


Other factors supporting market growth include supportive government regulations, increasing awareness, adoption of green technologies, and technological advancements. Increasing investments by vendors in advancements in hydrogen storage, and increasing demand of fuel cell vehicles further boosts the market growth.
  
Asia-Pacific generated the highest revenue in the fuel cell industry in 2018, and is expected to lead the global market throughout the forecast period. The increasing awareness among consumers, and rising environmental concerns drive the fuel cell market growth in the region. The governments in the region are investing significantly to promote the adoption of fuel Cell. The increasing application of fuel cells in commercial, and transportation sector further supports the market growth in the region. The increasing penetration fuel cell electric vehicles, and significant increase in power consumption accelerates the adoption of fuel cells in the region.

The Phosphoric Acid Fuel Cells (PAFCs) use liquid phosphoric acid, ceramic electrolyte and a platinum catalyst. PAFCs operate at a higher temperature, and are capable of handling small amounts of fuel impurities. PAFCs are used in high-energy demand applications, such as hospitals, schools, and manufacturing and processing centers. Solid Oxide Fuel Cell (SOFCs)


are the highest temperature fuel cells, operating at about 1800 degrees Fahrenheit. SOFCs use a dense layer of ceramic as an electrolyte, a non-platinum catalyst, and are commonly fueled by natural gas. SOFCs can achieve electrical efficiencies of 50% to 60%, and 70%-80% in CHP applications. SOFCs are used in applications such as small residential auxiliary power units, and large-scale stationary power generators for buildings and businesses.

The well-known companies profiled in the report include Aisin Seiki Co. Ltd., Ceres Power Holdings PLC, Plug Power Inc., Panasonic Corporation, Ballard Power Systems, Inc., Nedstack Fuel Cell Technology, Horizon Fuel Cell Technologies, Intelligent Energy Limited, Mitsubishi Hitachi Power Systems, Ltd., and Toshiba Fuel Cell Power Systems Corporation. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com





Greenhouse Film Market Insights and In-Depth Analysis 2019-2026 with Types, Products and Key Players


New York, NY 16 Jan 2020 :The global greenhouse film market is estimated to reach USD 8.3 billion by 2026 growing at a CAGR of 9.8% during the forecast period, according to a new study published by Polaris Market Research. The report ‘Greenhouse Film Market Share, Size, Trends, & Industry Analysis Report, By Resin Type (Low Density Polyethylene, Linear Low-Density Polyethylene, Polyvinyl Chloride), By Width (4.5M, 5.5 M, 7M, 9M), By Thickness, By Application, By Regions: Segment Forecast, 2019 – 2026’ provides an extensive analysis of present market dynamics and predicted future trends. In 2018, the Low-Density Polyethylene segment accounted for the highest share in the global greenhouse film industry in terms of revenue. North America was the leading contributor to the global market revenue in 2018.

The increase in the population worldwide and growth in global food demand majorly drives the market growth. The ability to produce high quality crops throughout the year, lesser use of water for crop cultivation, improved crop quality, and increased level of control over crop growth boost the market growth. Growing urbanization, need to enhance agricultural yield, rising investments by government organizations on agricultural schemes, and increasing focus on nutritious food products and indoor farming accelerate the market growth. New emerging markets, technological advancements in farming methods, growing demand and area used for greenhouse protected cultivation would provide growth opportunities in the market in the coming years.


Polyethylene plastic is available in two different strengths; commercial grade for large industrial applications and utility grade for personal use. Polyethylene plastic usually lasts for a year or two. Polyvinyl Plastic is expensive, durable offer high strength. However, the most durable greenhouse plastic is polycarbonate plastic. It is a twin wall, polyethylene plastic that maintains heat and humidity with the ability to last for up to a decade.
  
In 2018, North America generated the highest market share in terms of revenue in the greenhouse film industry. The growing urbanization, and rising population has accelerated the market growth in the region. A significant rise in the demand for organic and chemical free food products supports the market growth in the region. The technological advancements in farming methods, and increasing need for controlled environment for high quality crops further improves the market growth rate. Asia-Pacific is expected to grow at the highest rate during the forecast period owing to significant growth of population, government schemes, and strong technical expertise in agricultural practices. Technological advancements and established R&D institutes in China and Japan further supports the market growth.


The well-known companies profiled in the Greenhouse Film market report include Polifilm Extrusion GmbH, Essen Multipack Limited, Ginegar Plastic Products Ltd, Beijing Kingpeng International Hi-Tech Corporation, Thai Charoen Thong Karntor Co., Ltd, Central Worldwide Co., Ltd, Berry Global Group, Inc., The Dow Chemicals Company, Agriplast SRL, and Lumite, Inc. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com



Monday, 13 January 2020

High Performance Composites Market Demand, recent trends, Major Driving Factors and Business Growth Strategies 2026


New York, NY 13 Jan 2020 : The global high-performance thermoplastics market size is estimated to reach USD 65.6 billion by 2026 according to a new report by Polaris Market Research. The report “High Performance Thermoplastics Market Size, Share & Industry Report By Product Type (Polyamides, Polyphenylsufone, Sulfone Polymers, Liquid Crystal Polymers, Aromatic Polyketones, Polyethersulfone), By Application (Electrical & Electronics, Automotive, Aircraft, Industrial), By Regions, & Segment Forecast, 2019 – 2026” provides competent analysis of current market position and portrays future market trends.

High Performance Thermoplastics are advanced polymeric solutions that abide by industry specific applications. Largely, the demand is driven by the increased application in interior and exterior aerospace and automotive structures. HPTP exhibits excellent properties such as high temperature resistance, high chemical resistance and superior mechanical properties under severe conditions. These properties make it ideal for use in such demanding conditions with a healthy market growth to boast.


HPTP’s are currently the material of choice to be used in aircrafts when over some decades back, major components in aircraft were assembled with aluminum as chief component. This aluminum has made way for high-performance plastics and high-performance carbon fibers. These high-performance thermoplastics are light-weight and resist high temperatures that lead to fuel optimizations.

High-performance thermoplastics are the desired material in large industries such as electrical and electronics and industrial applications. Thermoplastics have seen increasing demand in emerging economies such as India and China. A rousing demand in consumer electronic products has significantly attributed success to market growth in thermoplastics. A rising population on a global scale and increasing disposable incomes has powered demand for these products in end-use industries that include thriving growth for market. A sizeable middle-class population and growing urbanization has boosted demand for advanced and modern electrical and automotive products. The lower costs attributed to the product and advancements in product quality have significantly contributed to robust growth of high-performance thermoplastics.
  
The consequence of choosing the wrong material can prove costly. Aerospace and mass transit industries have a very negligible scope for errors and hence any component failure can only prove to be highly disastrous. High-performance thermoplastics are higher-priced but provide great thermal resistance than other engineering polymers. HTTP’s also provide greater thermal stability both in short and long run.


Asia Pacific is the leading player for high performance thermoplastics owing to high development of its constituent countries. Japan is a fast-growing and productive country that is leader in electrical and electronics industry which hold true for HPTP’s growth also. Europe and America also have taken gigantic strides in automotive and aircraft industries that impact the HPTP positively. MEA and Africa are tagged with positive market growth for HPTP market.

The players are competing on grounds of modification of existing polymer type via intensive Rand D efforts and processing techniques. The key players in High Performance Thermoplastics Market include BASF, DowDuPont, SABIC, Solvay, Victrex, Royal DSM, Asahi Kasei, DIC Corporation and Honeywell International, Inc.


About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.

Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




Hematologic Malignancies Therapeutics Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026


New York, NY 13 Jan 2020 : The Global Hematologic Malignancies Therapeutics Market Size is anticipated to reach over USD 87.0 Billion by 2025 according to a new research published by Polaris Market Research. 

Hematological malignancy is a type of cancer that affect the bone marrow, blood, and lymph nodes. They include several forms of myeloma, leukemia, and lymphoma. According to an industry report in 2011, Hematological malignancies constituted 9% of all newly diagnosed malignancies in the U.S. specifying that lymphomas are more prevalent than myeloma or leukemias. Excluding Hodgkin’s lymphoma as well as acute lymphocytic leukemia, these types of malignancy are usually related to growing age. Hence, considering the aging worldwide population, malignancy type is more probable to become more prevalent.

The global Hematologic Malignancies Therapeutics Market growth is majorly driven by the increasing focus on development for novel treatments and growing occurrence of blood cancer. Currently, blood malignancies are the second most leading cause of cancer deaths and the 5th most common cancer. The three most common types of blood cancers are multiple myeloma leukemia, and lymphoma. Each year, approximately 400,000 people are diagnosed with lymphoma and more than 300,000 people are diagnosed with leukemia globally. In addition, inventions of novel drugs for blood cancer and its regulatory approvals are anticipated to bolster the market growth. For instance, in 2015, Pfizer announced that its antibody-drug conjugate- inotuzumab has received USFDA approval for acute lymphoblastic leukemia.  


The Global Hematologic Malignancies Therapeutics Market is segmented on the basis of type, therapy, and geography. Based on type, the market is segmented into leukemia, lymphoma, multiple myeloma, and others. The leukemia is further segmented into acute lymphocytic leukemia, chronic lymphocytic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. On the basis of type, leukemia was estimated to dominate the market. The major market share is due to availability of products such as Imbruvica, Rituxan, and Glivec, which are estimated to be the highest revenue generating drugs. On the basis of therapy, the global Hematologic Malignancies Therapeutics Market is segmented into Chemotherapy, Radiotherapy, Immunotherapy, Stem Cell Transplantation, and Others. Amongst all the therapies, chemotherapy is the most commonly used treatment with a particular drug or combination of drugs used.
  
On the basis of region, the global Hematologic Malignancies Therapeutics Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America was estimated to dominate the global market. The dominance is majorly attributed to the high presence of key market players, availability of branded drugs, established healthcare organization, and increasing government support in the region. However, Asia Pacific is expected to dominate the global market during the forecast period. Increasing awareness about early diagnosis, availability of effective treatment in emerging countries, such as India and China, growing healthcare expenditure, and high unmet clinical needs of patients, are some of the factors anticipated to significantly boost the market in the Asia Pacific.


Some major key players in global Hematologic Malignancies Therapeutics Market includes Pfizer, Inc., F. Hoffmann-LA Roche ltd, Sanofi-Aventis, Bristol-Myers Squibb Company, AbbVie, Inc., Novartis AG, GlaxoSmithKline PLC, Celgene Corporation, Johnson & Johnson Services, Inc., and Takeda Pharmaceutical Company limited among others. The object of the key market players is to deliver better chronic care administration while keeping the cost low. In addition, the companies are concentrating on producing easy-to-use monitoring devices that can aid patients to accomplish conditions including diabetes or heart diseases better by avoiding costly medical processes.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




Geriatric Medicines Market Size 2026 | Top Companies, Trends, Growth Factors Details by Regions, Types and Applications


New York, NY 13 Jan 2020 : The Global Geriatric Medicines Market Size is anticipated to reach over USD 1,157.34 billion by 2026 according to a new research published by Polaris Market Research. 

Geriatric medicines, also called geriatrics is a division of medicines associated with preventive, clinical, remedial, and social aspects of disease generally amongst people that are aged over 65 years or more. In response to the needs of an aging population, demand for geriatric medicines and appropriate cure has developed rapidly during last decades. The proper medical care for the geriatric patients across the range of ill health conditions includes co-morbid complications such as syncope, cerebral aging, and falls among others.

The global geriatric medicines market is majorly driven by the factor including a rise in geriatric populations. According to the Eurostat, the number of people aged 65 years and above is expected reach 141 million by 2050 globally. In addition, the high market growth is expected on account of the increasing occurrence of numerous target disorders in the geriatric population, the demographic modification, the rising trend in lifestyle-associated risk aspects, and the considerably developed access to economic medicine across the developing and emerging regions.


Continuous R&D activities commenced by key players and pharmaceutical companies to provide to the patient demand is expected to gain the significant outcomes during the forecast period. Increasing occurrence of chronic ailments, refining healthcare organization in emerging economies, increasing acceptance of medical tourism, government initiatives as well as support to provide timely care, and increasing number of specialty clinics are some of the other factors driving of the geriatric medicines market. However, difficulties associated with drug compatibility, lack of patient involvement in clinical trials, and side effects associated with the medications are the factors hampering the market growth.
  
The global Geriatric Medicines Market is segmented on the basis of therapeutic category, therapeutic condition, and geography. On the basis of therapeutic category, the global geriatric medicines market is segmented into Analgesics, Antihypertensive, Statins, Antidiabetics, Proton Pump Inhibitor, Anticoagulant, Antipsychotic, and Antidepressant. Pain as an indication is associated with old age and the middle age population unveils the high occurrence rate of pain related syndromes. Based on current trends and the demand for proper therapy, the market is anticipated to witness high growth for therapeutic conditions during the forecast period. On the basis of therapeutic conditions, the global geriatric medicines market is segmented into Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, and Respiratory. In 2017, the cardiovascular disease is estimated to be the dominating segment primarily due to the high proliferation of several cardiac disorders such as coronary artery disease, stroke, and hypertension.


North America is estimated to dominate the global Geriatric Medicines Market. The existence of developed healthcare facilities, favorable reimbursement policies, and the easy availability of important as well as life-saving medicine has significantly enhanced the average life expectancy rates in North America. Moreover, the number of people that are over 65 to 70 years suffering several target ailments is increasing continually which is further anticipated to boost the geriatric medicines market during the forecast period.

Some major key players in global Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com




Breast Lesion Localization Methods Market Analytical Overview, Growth Factors, Demand and Trends Forecast to 2026

New York, NY 13 Jan 2020 :The global breast lesion localization methods market is estimated to reach USD 1.98 billion by 2026 and is estimated to grow at a CAGR of 14.9% between 2018 to 2026 as per a new study published by Polaris Market Research. The report ‘Breast Lesion Localization Methods Market Size by Type (Wire Localization Biopsy, Radioisotope Localization (Radio-Guided Occult Lesion Localization, and Radioactive Seed Localization), Magnetic Tracer, and Others); and by Regions Segments & Forecast, 2018 – 2026’ provides a deep dive analysis and estimates the future trends.

The abnormal changes in breast cells due to injuries or problems is stated as breast lesion. Benign breast disease promotes the growth of tumors in non-cancerous areas wherein there is a rapid growth of breast cells forming lumps inside the breasts. However, on the other hand malignant lesions grow hysterically and are dangerous since they can be fatal. There is no particular age limit for this condition to occur in women however it is seen commonly during the reproductive years and majority of the complaints are from the women between the age group of 40 to 69 years old. The investigative analysis of this disease can be done by both physical examinations, studying patient’s medical history and by using ultrasound, mammography, MRI and through tissue sampling. If the examination evaluates that the growth is malignant then it is needed to execute lesion surgical treatment. Lesion localization devices are used to perform treatments on these ailments. The selection of ideal localization approach is additionally an essential choice as it is taken by medical professionals relying on the variety of elements consisting of efficiency, mean localization time, convenience of usage, expense of surgical treatment, security, and age of individual.

  
Rising instances of breast cancer across the globe is one of the major factors driving the overall breast lesion localization method market. According to American Institute for Cancer Research, there were 2 million new cases of breast cancer in 2018 with Belgium and Luxembourg to have most of the cases followed by Netherlands and France. Canada and U.S. also have a higher occurrences of breast cancer with approximately 84 among 100,000 individuals. This has made the governments of different countries to introduce compensation policies for diagnosis of mammary gland cancer, pre-surgical examinations, biopsy and other options of treatments. Due to increased breast cancer occurrences and rising awareness among the people have helped the market to grow globally thereby implementing breast lesion localization procedures.

Wire localization biopsy, commonly known as wire guided biopsy or needle localization, is estimated to control the breast lesion localization methods market in 2018.  This was majorly due to its increased usage by medical practitioners, growing implementation in hospitals and cancer diagnostic centers. Magnetic tracers on the other hand is anticipated to be one of the fastest growing segments within this market as there has been a significant adoption of new technology such as magnetic sentinel node and occult lesion localization (MagSNOLL) over traditional methods such as wire localization.


Radioisotope seed localization on the other hand is taken into consideration as one of the most favored approach among all radioisotope localization techniques because of its advantages such as simplicity of localization couple of weeks prior to the excision surgical procedure as well as minimal demand for re-operation. Early device adoption and a paradigm shift from traditional to scientifically advanced treatment procedures and products, the North American region is predicted to lead the market in 2018. This is followed by Asia Pacific region which is expected to grow at a higher rate due to increasing medical infrastructure, rise in the spending capacity of the people from countries such as India and China, growing awareness about breast cancer and large target population.

Some major key players in this industry include Argon Medical Devices, Inc., Cook Medical, Cianna Medical, CP Medical, Inc., C.R. BARD, Inc., STERYLAB, and SOMATEX Medical Technologies GmbH among others.

About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com